October 15, 2020 | International, Land, Security
The gun that will replace both the M249 Squad Automatic Weapon and the M16/M4 rifle/carbine weapons — and add a new, widely distributed caliber to the U.S. military inventory for the first time in decades — is less than two years away.
The Next Generation Squad Weapon finished its first prototype test event in September. The three previously selected offerings came from Sig Sauer, Textron Systems and General Dynamics Ordnance.
Brig. Gen. David Hodne, Infantry School commandant and Soldier Lethality Cross Functional Team director, along with Brig. Gen. Anthony Potts, head of Program Executive Office Soldier, gave updates to Army Times ahead of the Association of the U.S. Army Annual Meeting and Exposition.
Concurrently, the Army in April has also selected two companies, L3 Technologies and Vortex Optics, to compete for the fire control for the weapons system.
Sig Sauer's design looks much like a conventional assault rifle while GD is using a bullpup design, which shortens the length by building the magazine feed into the weapon stock. Textron has built its weapon around the cartridge, which is unique to them, a cased telescope item that has the projectile inside of the casing to reduce weight.
Back in April, each of the companies provided 15 rifles, 15 automatic rifles and 180,000 cartridges using the government-developed 6.8mm projectile.
The 6.8mm projectile was chosen after decades of testing and evaluation showed that 5.56mm lethality at mid-ranges on the battlefield was inadequate and existing 7.62mm could be outperformed by the 6.8mm round and save weight for the soldier.
The new caliber also gives the soldier both a rifle and automatic rifle firing the same round, both effective past the 600m mark of existing light calibers.
Following the September testing, the companies will have six months until their next prototype test, scheduled to begin in February.
During the annual Maneuver Warfighter Conference at Fort Benning in Georgia, Maj. Wyatt Ottmar, project officer over NGSW for the Soldier Lethality CFT, laid out some of the recent developments and next steps for the weapons system.
Ottmar noted that Sig Sauer provided a combined steel lower and brass upper ammunition cartridge to reduce weight. A contract is expected to be awarded to one of the three companies this coming fiscal year with fielding to start in the fourth quarter of fiscal year 2022, or sometime between August and October 2022, to Infantry, Stryker and Armor Brigade Combat Teams.
Ultimately, the weapon will be fielded to all close combat forces, including special operations forces, infantry, combat engineers and scouts.
The fire control is expected to field six months ahead of the weapon, Potts said. That will allow the NGSW producer to better integrate the optic with the weapon.
September 5, 2023 | International, Naval
AUKUS was announced two years ago. Now Congress must pass several bills to make the pact work, from export controls to submarine transfer authorities.
June 29, 2018 | International, Naval
By: David B. Larter and Aaron Mehta WASHINGTON ― In a move that could send shock waves through the global frigate market, Australia appears poised to announce that it has selected BAE Systems' Type 26 design for its new future frigate design. The Wall Street Journal reported Thursday that on June 29, the Australian military will make the formal announcement that BAE has won the AU$35 billion (U.S. $26 billion) contest to build nine frigates, which are being designed with anti-submarine warfare in mind. Under the competition guidelines, construction on the ship is scheduled to begin at the shipyards at Osborne in 2020. The design beat out two strong challenges from ships that, unlike the Type 26, already exist. The move is a major blow to Fincantieri, which had been pushing its anti-submarine warfare FREMM for the requirement. The Spanish shipbuilder Navantia, which already has a major operation in Australia, was also a strong competitor for the contract with its F-100 frigate design. In 2007, Navantia was selected to build the Australian air warfare destroyer. The competition also has implications for the Canadian frigate program, which is expected to announce a winner later this year, said Byron Callan, an defense analyst with Capital Alpha Partners. “The win is a positive for BAE because it's the first international order for the Type 26 and it may help position that ship type for Canada's Surface Combatant program that should be decided in late 2018,” Callan said. Canada has a 15-ship requirement. The unit price for the hull is about $850 million to $1 billion, which does not include some government-furnished systems. The U.K. has already agreed to buy eight of the Type 26 designs, with the goal of fielding them in the mid-2020s. BAE started building the first of three Type 26s it has under contract last year. The first warship is currently scheduled to enter service with the British Royal Navy in 2027 to start replacing the Type 23 fleet. Rolls-Royce with its MT30 gas turbine engine and MBDA with the Sea Ceptor anti-air missile are among the Type 26 subcontractors who could be significant beneficiaries from the Australian order. There has been speculation in the media that the decision to go with BAE may be driven, in part, by Australia's desire to secure strong terms with the U.K. as it negotiates a series of new trade agreements after Britain leaves the European Union. The announcement came just hours after the U.S. State Department announced it had clearedthe sale of $185 million in parts to help Australia connect its CEAFAR 2 phased array radar system with Lockheed Martin's Aegis combat system, with the goal of having both pieces of equipment aboard the future frigates. Andrew Chuter from London contributed to this report. https://www.defensenews.com/global/asia-pacific/2018/06/28/report-australia-selects-bae-for-frigate-design/
February 7, 2019 | International, Security, Other Defence
Blast injuries, burns, and other wounds experienced by warfighters often catastrophically damage their bones, skin, and nerves, resulting in months to years of recovery for the most severe injuries and often returning imperfect results. This long and limited healing process means prolonged pain and hardship for the patient, and a drop in readiness for the military. However, DARPA believes that recent advances in biosensors, actuators, and artificial intelligence could be extended and integrated to dramatically improve tissue regeneration. To achieve this, the new Bioelectronics for Tissue Regeneration (BETR) program asks researchers to develop bioelectronics that closely track the progress of the wound and then stimulate healing processes in real time to optimize tissue repair and regeneration. Paul Sheehan, the BETR program manager, described his vision for the technology as “not just personalized medicine, but dynamic, adaptive, and precise human therapies” that adjust to the wound state moment by moment to provide greater resilience to wounded warfighters. “Wounds are living environments and the conditions change quickly as cells and tissues communicate and attempt to repair,” Sheehan said. “An ideal treatment would sense, process, and respond to these changes in the wound state and intervene to correct and speed recovery. For example, we anticipate interventions that modulate immune response, recruit necessary cell types to the wound, or direct how stem cells differentiate to expedite healing.” The envisioned BETR technology would represent a sharp break from traditional wound treatments, and even from other emerging technologies to facilitate recovery, most of which are passive in nature. Under current medical practice, physicians provide the conditions and time for the body to either heal itself when tissues have regenerative capacity or to accept and heal around direct transplants. Most people are familiar with interventions that include casts to stabilize broken bones or transplants of healthy ligaments or organs from donors to replace tissues that do not regenerate. Passive approaches often result in slow healing, incomplete healing with scarring, or, in some unfortunate cases, no healing at all. Blast injuries in particular seem to scramble the healing processes; 23 percent of them will not fully close. Moreover, research shows that in nearly two thirds of military trauma cases — a rate far higher than with civilian trauma injuries — these patients suffer abnormal bone growth in their soft tissue due to a condition known as heterotopic ossification, a painful experience that can greatly limit future mobility. Although recent experimental treatments offer some hope for expedited recovery, many of these new approaches remain static in nature. For instance, some “smart” bandages emit a continuous weak electric field or locally deliver drugs. Alternatively, hydrogel scaffolds laced with a drug can recruit stem cells, while decellularized tissue re-seeded with donor cells from the patient help avoid rejection by the host's immune system. These newer approaches may indeed encourage growth of otherwise non-regenerative tissue, but because they do not adapt to the changing state of a wound, their impact is limited. “To understand the importance of adaptive treatments that respond to the wound state, consider the case of antibiotic ointments,” Sheehan explained. “People use antibiotics to treat simple cuts, and they help if the wound is infected. However, completely wiping out the natural microbiota can impair healing. Thus, without feedback, antibiotics can become counterproductive.” Recent technologies have begun to close the loop between sensing and intervention, looking for signs of infection such as changes in pH level or temperature to trigger treatment. To date, however, these systems have been limited to monitoring changes induced by bacteria. For BETR, DARPA intends to use any available signal, be it optical, biochemical, bioelectronic, or mechanical, to directly monitor the body's physiological processes and then to stimulate them to bring them under control, thereby speeding healing or avoiding scarring or other forms of abnormal healing. By the conclusion of the four-year BETR program, DARPA expects researchers to demonstrate a closed-loop, adaptive system that includes sensors to assess wound state and track the body's complex responses to interventions; biological actuators that transmit appropriate biochemical and biophysical signals precisely over space and time to influence healing; and adaptive learning approaches to process data, build models, and determine interventions. To succeed, the BETR system must yield faster healing of recalcitrant wounds, superior scar-free healing, and/or the ability to redirect abnormally healing wounds toward a more salutary pathway. DARPA anticipates that successful teams will include expertise in bioelectronics, artificial intelligence, biosensors, tissue engineering, and cellular regeneration. Further, DARPA encourages proposals that address healing following osseointegration surgery, which is often necessary to support the use of advanced prosthetics by wounded warfighters. DARPA will host a Proposers Day on March 1, 2019 in Arlington, Virginia, to provide more information to researchers interested in submitting a proposal for funding. Additional information is available at https://go.usa.gov/xENCQ. A forthcoming Broad Agency Announcement, to be posted to the Federal Business Opportunities website, will include full details of the program. https://www.darpa.mil/news-events/2019-02-06a